药品注册申请号：090020
申请类型：ANDA (仿制药申请)
申请人：OXFORD PHARMS
申请人全名：OXFORD PHARMACEUTICALS LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG No No AA 2011/10/19 2011/10/19 Prescription
002 GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG No No AA 2011/10/19 Prescription
批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级；罕用药状态通知信、审评文件、说明书、包装标签备注
2011/10/19 ORIG-1（原始申请） Approval
与本品相关的专利信息（来自FDA橙皮书Orange Book）
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
无
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
无
与本品治疗等效的药品
活性成分:GLYCOPYRROLATE 剂型/给药途径:TABLET;ORAL 规格:1MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
012827 001 NDA ROBINUL GLYCOPYRROLATE TABLET;ORAL 1MG Prescription Yes No AA Approved Prior to Jan 1, 1982 CASPER PHARMA LLC
040653 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No Yes AA 2006/08/31 ENDO OPERATIONS
040847 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2008/03/21 DR REDDYS LABS LTD
040821 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2008/12/29 RISING
040844 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2009/08/18 SUN PHARM INDS LTD
090020 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2011/10/19 OXFORD PHARMS
090195 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2012/09/21 VELZEN PHARMA PVT
202675 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2013/04/15 AUROBINDO PHARMA
091182 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2014/02/03 ADAPTIS
091413 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2016/06/20 NATCO
207201 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2017/01/03 APPCO
203657 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2018/11/30 ALEMBIC
212696 001 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 1MG Prescription No No AA 2024/07/10 QUAGEN
活性成分:GLYCOPYRROLATE 剂型/给药途径:TABLET;ORAL 规格:2MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
012827 002 NDA ROBINUL FORTE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription Yes No AA Approved Prior to Jan 1, 1982 CASPER PHARMA LLC
040653 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No Yes AA 2006/08/31 ENDO OPERATIONS
040847 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2008/03/21 DR REDDYS LABS LTD
040821 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2008/12/29 RISING
040844 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2009/08/18 SUN PHARM INDS LTD
090020 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2011/10/19 OXFORD PHARMS
090195 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2012/09/21 VELZEN PHARMA PVT
091182 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2014/02/03 ADAPTIS
091413 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2016/06/20 NATCO
207201 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2017/01/03 APPCO
202675 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2018/10/30 AUROBINDO PHARMA
203657 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2018/11/30 ALEMBIC
212696 002 ANDA GLYCOPYRROLATE GLYCOPYRROLATE TABLET;ORAL 2MG Prescription No No AA 2024/07/10 QUAGEN
更多信息
药品NDC数据与药品包装、标签说明书
参考引用1
参考引用2
©2006-2024 DrugFuture->U.S. FDA Drugs Database